Alan Magee

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair Munro, Shuo Feng, Leila Janani et al. · The Lancet Infectious Diseases · 2022 · 177 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Transcatheter coil occlusion of the arterial duct. Results of the European Registry

Alan Magee · European Heart Journal · 2001 · 120 citations · Full text

Medicine, Cardiology, Surgery +12

Internal validation of STRmix™ – A multi laboratory response to PCAST

Jo‐Anne Bright, Rebecca Richards, Maarten Kruijver et al. · Forensic Science International Genetics · 2018 · 97 citations · Full text

Natural Sciences, Chemistry, Process Validation +3

Patient-reported quality of life outcomes for children with serious congenital heart defects

Rachel L Knowles, Thomas G. Day, Angela Wade et al. · Archives of Disease in Childhood · 2014 · 79 citations · Full text

Medicine, Cardiology, Pediatrics +14

Atrial Septal Defect with Failure to Thrive in Infancy: Hidden Pulmonary Vascular Disease?

Rachel Andrews, Robert Tulloh, Alan Magee et al. · Pediatric Cardiology · 2002 · 53 citations

Medicine, Cardiology, Pediatrics +14